Doug Drysdale, Cybin CEO
Cybin says its psychedelic drug can sustain remission in depression patients
Cybin said its psilocin analog has the potential to wipe out symptoms in most patients with a serious form of depression, which marks a major …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
